Memorial Sloan-Kettering Cancer Center, IBM Collaborate on Watson Usage | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Memorial Sloan-Kettering Cancer Center, IBM Collaborate on Watson Usage

March 22, 2012
by Gabriel Perna
| Reprints

The New York City-based Memorial Sloan-Kettering Cancer Center (MSKCC) and IBM (New York City) are collaborating on the use of IBM’s Watson technology to help create a decision support tool will help doctors everywhere create individualized cancer diagnostic and treatment recommendations for their patients based on current evidence.

Watson gained notoriety when the artificial intelligence computer system beat the best Jeopardy! contestants in the world during a special two-episode version of the quiz show. The system can interpret natural language and uses statistical analysis, advanced analytics and an array of processors to search millions of pages in seconds and deliver evidence-based statistically-ranked responses.

For this collaboration, the computational power of IBM Watson and its natural language processing ability will team with MSKCC’s clinical knowledge, existing molecular and genomic data and repository of cancer case histories. The goal is to create an outcome and evidence-based decision support system. The system, would ideally in MSKCC’s eyes, give oncologists located anywhere the ability to obtain detailed diagnostic and treatment options based on updated research on how best to care for an individual patient.

According to MSKCC, their oncologists will assist in developing IBM Watson to use a patient’s medical information and synthesize a vast array of continuously updated and vetted treatment guidelines, published research and insights gleaned from the deep experience of MSKCC clinicians to provide an individualized recommendation to physicians.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).